Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Ationdo
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ationdo SR 50mg tablets
0407020AGBCABAC
|
Ationdo | Tapentadol | Central Nervous System | 1,154 |
|
Ationdo SR 100mg tablets
0407020AGBCACAD
|
Ationdo | Tapentadol | Central Nervous System | 1,008 |
|
Ationdo SR 150mg tablets
0407020AGBCADAE
|
Ationdo | Tapentadol | Central Nervous System | 442 |
|
Ationdo SR 200mg tablets
0407020AGBCAEAF
|
Ationdo | Tapentadol | Central Nervous System | 407 |
|
Ationdo SR 25mg tablets
0407020AGBCAAAI
|
Ationdo | Tapentadol | Central Nervous System | 153 |
|
Ationdo SR 250mg tablets
0407020AGBCAFAG
|
Ationdo | Tapentadol | Central Nervous System | 132 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.